Sound Income Strategies »

Mymd Pharmaceuticals shares owned by Sound Income Strategies

Quarter-by-quarter ownership of Mymd Pharmaceuticals (TNFA) shares owned by Sound Income Strategies from 13F filings

Historical chart of Sound Income Strategies investment in Mymd Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mymd Pharmaceuticals held by Sound Income Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mymd Pharmaceuticals by Sound Income Strategies

Quarter filed Position value Share count Share price at filing
2024-09-30 $2 1 2.00

More positions owned by Sound Income Strategies

Hercules Technology Growth Capital (HTGC)
Ares Capital Corporation (ARCC)
Sixth Street Specialty Lending (TSLX)
Golub Capital BDC (GBDC)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Owl Rock Capital Corporation (OBDC)
Vaneck Vectors Etf Tr Emerging Mkts Hi (HYEM)
Ishares Jp Mrgn Em Hi Bd (EMHY)
First Tr Exchng Traded Fd Vi Tcw Emerging Mkt (EFIX)
Pennantpark Floating Rate Capi (PFLT)
Tidal Etf Tr Sound Enhanced (FXED)
Common Stockblackstone Secd Lending Business Development Company (BXSL)
At&t (T)
International Business Machines (IBM)
Omni (OMC)

View all positions for Sound Income Strategies

Top funds holding Mymd Pharmaceuticals

Geode Capital Management
Vanguard Group
Virtu Financial
BlackRock
Parallel Advisors
Group One Trading
Morgan Stanley
Wells Fargo & Company
Sandy Spring Bank
Harbor Investment Advisory
Redwood Wealth Management Group
Royal Bank of Canada
Tower Research Capital
ORG Wealth Partners
Arvest Investments

View all funds holding Mymd Pharmaceuticals